Robert has considerable cross spectrum experience in the vape and CBD sectors he is highly regarded for the knowledge & support that he provides into the industries and the advice and guidance he gives to group and independent retailers. Robert is the Managing Director for Arcus Compliance who are rapidly becoming the ‘go to’ vape and CBD compliance agency in Europe. He was recently the Group Managing Director for Eco Vape Ltd, an own label and OEM Manufacturer of vape e-liquid. Robert has an additional directorship with Dushey Med Ltd, who cultivate hemp/cannabis in Colombia, selling bulk derived products (CBD) across Europe. You may have seen Robert speak at the Hemp and CBD Expo held at the NEC in Birmingham where he facilitated the subject presenters. Robert has authored several articles in retail magazines, he works closely with regional Trading Standards officers and the MHRA regarding vape compliance and CBD product safety.
Sébastien is working at ingésciences since 2015. He developed a vaping machine named U-SAV in 2015-2016 and is an expert on AFNOR, CEN and ISO committees on vaping products since 2016 where he leads the development of a document related to a vaping regime suitable for direct-lung devices. He defended with success a PhD in January 2021 titled "Thermodynamics contribution to the understanding of the electronic cigarette functioning" and published many papers including two critical review about emission analysis in collaboration with Roberto A Sussman [ORCID: 0000-0002-7802-7233].
Dr. Stefanie Scheffler is a chemist with a doctorals degree in technical chemistry and experiences in cell culture, in vitro inhalation toxicology and proteomics as well as human and environmental risk assessment including exposure assessment. Since 2017, Stefanie is employed at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM as a scientist in the department “Regulatory Affairs” in the division “Chemical Safety and Toxicology”. At her current position, Stefanie’s work focuses on the evaluation of studies in the field of human and environmental toxicity as well as on exposure and risk assessments for various different products, e.g. biocides, food additives, plant protection products, cosmetic products and consumer products. Stefanie first gained experiences with nicotine delivery systems when she was working at Cultex Laboratories in 2014 and 2015, performing in vitro inhalation studies with e-cigarette aerosols. At Fraunhofer ITEM, she is engaged in different projects assessing the health consequences of e-cigarette consumption. In this context, Stefanie leads a project to develop a device for standardized e-liquid testing to improve consumer safety.
Christopher Snowdon is the head of lifestyle economics at the Institute of Economic Affairs. He is a regular contributor to the Spectator, Telegraph and Spiked, and is the author of ‘Polemics’ (2020), ‘Killjoys’ (2017), ‘Selfishness, Greed and Capitalism’ (2015), ‘The Art of Suppression' (2011), ‘The Spirit Level Delusion’ (2010) and ‘Velvet Glove, Iron Fist’ (2009). He is the editor of the Nanny State Index.
Ciprian is both a serial entrepreneur with over 12 years’ experience in the vaping industry, and a founder and board member of the only Pan-European vaping organisation, the Independent European Vape Alliance (IEVA).
Enthusiastic proponent of nicotine-based alternatives as a way to combat smoking, he is committed to making harm-reduction a reality.
As a board executive, Ciprian has been highly involved in IEVA’s communication activities and led recruitment and membership management during the last 5 years, against the background of an ever more complex EU regulatory landscape. This has given him an unparalleled level of interaction with main sector players from all over the world, and a deep understanding of what makes the industry tick.
Marija is an international regulatory specialist. She has worked in Spain and Serbia on a broad range of national and cross-border policy issues, dispute resolution and rule of law. She holds an LLB degree in law from the University of Belgrade and a Master’s in International Security from Institut Barcelona d’Estudis Internacionals.
Marija drives legal analysis for ECigIntelligence globally. She has developed a number of data products and policy tracking tools such as our daily alerts, Regulatory Burden Index, and the Compliance Calendar, among others.
Marina Murphy PhD is a scientific communications and engagement professional with more than 25 years of experience including 14 years in the tobacco and nicotine sector. With a background in chemistry, she also has broad outreach, engagement and advocacy experience. She has previously worked for JUUL Labs as Head of Public Health Advocacy and spent nearly ten years working for British American Tobacco where she was a driving force behind a communications strategy designed to reflect BAT’s transparent approach to scientific communication. The strategy was designed to provide clear communication and engender debate on the company’s ambitious tobacco harm-reduction research program. Over these ten years, Marina held various roles, including Head of Scientific Media Relations, International Scientific Engagement Manager and Scientific Communications Manager. Marina has also worked as a journalist, editor and in PR and has published in several high-profile publications including New Scientist, The Irish Times and science|business
Andrea Patton, PhD is a Behavioural Epidemiologist and Head of Prevalence Research within the Centre for Substance Use Research Ltd (CSUR), Glasgow, United Kingdom. Andrea has over 15 years of experience working in public health for academia, regulatory bodies and industry leaders in Europe and the United States.
Michael Landl is the Director of the World Vapers' Alliance, a consumer group that fights for vaping as a less harmful alternative to smoking. Landl has been a vocal advocate for vaping and tobacco harm reduction for several years. He is from Austria and is based in Vienna. He is an experienced policy professional and a passionate vaper. He studied at the University of St. Gallen and worked for several public policy outlets and the German Parliament.
Richard is a RSB/BTS and European Registered Toxicologist (ERT) and has been working as a desk-based toxicologist at bibra for over 20 years. His special interests include the application of health risk assessment methodology to mammalian toxicity data sets in order to derive robust conclusions on toxicological acceptability of exposures and on health risks to exposed populations. In recent years he has been helping companies assess the potential human health effects of their ENDS products, other nicotine delivery devices (e.g., oral products), and cannabinoids (e.g., CBD). This has included assisting in the production of toxicity profiles on 100s of e-liquid ingredients (e.g. for EU TPD, UK MHRA, and US FDA PMTA submissions). Also in proposing acceptable levels for these ingredients, and tolerable levels for the ENDS emissions and extractables/leachables.
Jeannie Cameron is a Public Affairs & Regulatory professional with over 25 years’ experience & is currently CEO of JCIC International, a UK based strategic advocacy consultancy focused on bespoke advice & engagement. She is a leading expert on the WHO Framework Convention on Tobacco Control FCTC, including attending its development in Geneva & the development of its subsequent Protocol on Illicit Trade. She provides advice on national implementation & matters relating to the FCTC COP. She founded JCIC in 2011 but took an 18 month break in January 2020 to work as Vice President, International at Juul Labs. Before JCIC she headed BAT’s Int’l Political & Regulatory Affairs Division focusing on int’l public health & anti-illicit trade advocacy. JCIC’s clients have included multi-nationals & start-ups. She has an LLM in international law; a degree in politics /communications & a graduate diploma in finance & economics. She earned a distinction from King’s College University London for a dissertation on Emerging International Public Health Issues – Human Rights, Harm Reduction & the Framework Convention on Tobacco Control (FCTC). She has been a parliamentary advisor & chief of staff as well as a civil servant in the International Legal Section of the Australian Cabinet. She has served as Co-Chair of OECD’s Charting Illicit Trade Taskforce. She has been an active commentator in the public health policy area of harm reduction, as well as public admin & governance reform.
An experienced legal, regulatory & compliance department leader, Patricia I. Kovacevic’s career comprises leading senior legal & regulatory positions with tobacco & cannabis corporations, including Philip Morris International & Lorillard, as well as partner roles with premier global law firms. Her expertise includes senior management roles & leading multinational, cross-disciplinary teams, with focus on corporate law, FDA & EU regulatory, compliance, M&A, US & global food, drug, nicotine & consumer goods regulation, cannabis/CBD regulation, external affairs & the legal framework applicable to marketing, media communications, investigations, FCPA, trade sanctions, privacy, intellectual property, product development & launch. She also led cross-disciplinary teams engaged in scientific research efforts. Kovacevic served on various trade association bodies & conference advisory boards. She authored several articles on nicotine regulation, co-authored an academic treatise, “The Regulation of E-Cigarettes” & is often invited as a keynote speaker or panelist before global conferences & government agencies public hearings. Kovacevic is an attorney admitted to practice in New York, before the U.S. Tax Court, before the U.S. Court of International Trade & before the Supreme Court of the United States. She holds a Juris Doctor (doctor of law) degree from Columbia Law School in New York & completed the Harvard Business School “Corporate Leader” executive education program.
First came across e-cigs in 2011 and switched completely from a heavy smoking habit within a few days. As he watched regulation advance he felt the voice of people like himself was not being heard. The NNA Ireland gives them that voice and Tom is proud to serve as a trustee.
Flora Okereke is Head of Regulatory Insights and Foresights at BAT, responsible for the analysis and forecasting of international regulatory developments on behalf of BAT’s 180-plus global markets. Flora also coordinates BAT’s policy responses to global institutions. She has previously held several senior country, regional and global roles at BAT, including legal, corporate and regulatory affairs director for West Africa; head of regulatory affairs for Africa, the Middle East and Eastern Europe; global head of regulatory strategy and engagement; and senior director of government affairs and international policy at Reynolds American Incorporated Services, a subsidiary of RJR Tobacco based in Washington, D.C. Flora was called to the Bar of England and Wales (Middle Temple) and later admitted as a solicitor by the Law Society.
R. Emma, MSc and PhD in Translational Biomedicine, is assistant professor at the Department of Clinical and Experimental Medicine of the University of Catania. She is also a researcher of the Center of Excellence for the acceleration of Harm Reduction (CoEHAR) of the University of Catania. Her research activity deals with respiratory diseases, harm of cigarette smoking and health benefits of quitting. She has experience in toxicological in vitro studies and in exposure methods to smoke/aerosol using automated instruments (smoking/vaping machines).
Liam Humberstone is Technical Director at Totally Wicked Limited. His involvement with standards and regulations for e-cigarettes and e-liquid started with a notorious legal challenge, but he has since worked collaboratively with regulators at UK National, European and other International levels. His background is in design engineering and scientific research, and he has been involved in the e-cigarette industry since 2011.
Ian Tindall is the Innovation and Marketing Director of Cerulean, a respected manufacturer of laboratory test equipment for the vaping industry. Ian is responsible for defining the new products that Cerulean brings to market and has been instrumental in expanding the Cerulean portfolio to ENDS testing. His working life has been concerned with the design of scientific and industrial instrumentation, firstly for VG Scientific then for Zellweger Analytics (now part of Honeywell) before joining Cerulean in 2004. He has presented scientific papers at CORESTA, TSRC and ACS on subjects concerned with tobacco testing. He has had numerous articles published in trade journals and holds patents in topics as diverse as x-ray source design and electrodes for gas detection. Ian graduated from the University of Manchester Institute of Science and Technology with a degree in Analytical Chemistry and has a PhD in Physical Chemistry from Manchester University in the UK.
Ian is an independent consultant with expertise in regulatory and scientific aspects of nicotine and tobacco products. Ian most recently worked for JUUL Labs as Senior Director of Clinical and Regulatory Affairs EMEA, and previously he was Director of Tobacco Research at Celerion, a provider of clinical research capabilities and expertise to the tobacco and e-cigarette industry. Prior to that, Ian was Principal Scientist and Head of Clinical Research at British American Tobacco's central research and development centre in Southampton, U.K. He specializes in the biological and psychological effects of nicotine, clinical and pre-clinical studies to assess the biological effects of electronic cigarettes and tobacco heating devices, and the scientific basis for regulation. Prior to working in the industry, Ian pursued an academic career as a Lecturer in Physiology at the University of Manchester and an Assistant Professor in Biology at McMaster University in Hamilton, Canada. Ian is a highly-cited scientific researcher and writer, contributing to more than 50 peer-reviewed papers and book chapters which have generated over 2,400 citations.
Pete Lomas has over 25 years’ experience in product development, most notably with medical devices and ENDS products. Before joining Broughton as a consultant, Pete was responsible for the development of electronic vapor and heated tobacco products at Imperial Brands. He has a proven background in novel and innovative product development, with over 80 published patent applications to his name. Pete has also been involved with several PMTA and MAA submissions related to ENDS products.
Xiang is the Principal Scientist of Scientific Horizons Consulting (SHC) with the research focus on electronic nicotine delivery system (ENDS) and pulmonary drug delivery technologies. His scientific expertise on ENDS or e-cigarettes ranges from aerosol science and chemistry to behavior and clinical studies. Some of his recent works include leading the submission of the pre-market tobacco product application (PMTA) to the FDA and launching the ENDS actual use study in the United Kingdom. Before joining SHC, Xiang was the Senior Scientist of Envista/Danaher, where he led the research and development and the regulatory registrations (including EPA and FDA) of products in healthcare infection prevention segment. Xiang holds a Ph.D. from UC Berkeley with the specialized research focus in material science and chemistry. During his academic career, Xiang has published 10+ peer-reviewed papers and is the inventor of 3 US patents.
Markus Lindblad is Head of External Affairs at Haypp Group, an e-commerce group present in eight countries with eleven e-commerce brands which served more than 790,000 active consumers in 2022. Haypp Group aims to reduce tobacco-related deaths globally whilst promoting healthier enjoyment for millions. Mr Lindblad has extensive experience in regulatory affairs, public affairs, and communications. Before Haypp Group, he was Head of Corporate and Regulatory Affairs in Sweden and Norway at BAT.